Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996–2011: an observational study

BMC Infectious Diseases

Jan Kristian Damås³  Bjørn Olav Åsvold¹  Erik Solligård⁴  Åsa Askim⁴  Arne Mehl²  Julie Paulsen⁵ 

[1] Department of Endocrinology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway;Department of Medicine, Levanger Hospital, Nord-Trøndelag Health Trust, Levanger, Norway;Department of Infectious diseases, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway;Clinic of Anaesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway;Faculty of Medicine, Institute of Cancer Research and Molecular Medicine, Trondheim, N-7491, Norway

关键词: Focus of infection;    Comorbid disease;    Organ failure;    Sepsis;    Bacteremia;    Staphylococcus aureus;   

Others  :  1135419
DOI  :  10.1186/s12879-015-0849-4

 received in 2014-11-06, accepted in 2015-02-19,  发布年份 2015

【 摘 要 】

Background

Staphylococcus aureus is one of the most common and lethal causes of bloodstream infection and the incidence is increasing. We carried out a prospective observational study of patients with Staphylococcus aureus bloodstream infection and sepsis in Nord-Trøndelag county in Norway from 1996–2011. The main outcome of interest was all-cause mortality within 30 and 90 days.

Methods

Positive blood cultures were registered prospectively by the microbiology laboratory and clinical variables were retrospectively registered from patients’ hospital records. The severity of sepsis was assigned according to the 2001 International Sepsis Definition Conference criteria. The association between clinical characteristics and mortality was studied using logistic regression analysis, and adjusted 30- and 90-day mortality risks were estimated.

Results

Among 373 patients, the median age was 74 years and 60.3% were male. 0.8% of the patients were diagnosed with MRSA. 29.8% of the patients developed severe sepsis and 12.9% developed septic shock. The all-cause mortality was 14.5%, 27.3% and 36.2% at 7, 30 and 90 days, respectively. Compared to patients with sepsis without organ failure (Mortality risk 13.3%, 95% CI 7.5-16.3%), the 30-day mortality risk was 3-fold higher among those with severe sepsis (39.9%, 95% CI 29.5-48.5%) and more than 4-fold higher for those with septic shock (57.3%, 95% CI 42.5-72.2%). The 30-day all-cause mortality varied by focus of infection, with the highest 30-day mortality risk among those with a pulmonary focus (42.4%, 95% CI 26.0-58.5%) and unknown focus of infection (38.7%, 95% CI 27.5-48.2%). The mortality risk did not differ between the first and second halves of the study period with a 30-day mortality risk of 27.3%, (95% CI 18.1-33.1%) for 1996–2003 versus 27.4% (95% CI 19.4-31.4%) for 2004–2011. The same pattern was seen for 90-day mortality risk.

Conclusion

Staphylococcus aureus bloodstream infection carries a high case fatality rate, especially among those with severe sepsis and septic shock and among those with a pulmonary or unknown focus of infection. There was no decrease in 30- or 90-day mortality risk during the study period. This underscores the importance of continuing surveillance and efforts to improve the outcome of this serious disease.

【 授权许可】

   
2015 Paulsen et al.; licensee BioMed Central.

【 参考文献 】

• [1]Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD: Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003, 187(9):1452-9.
• [2]Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gur D, et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16(11).
• [3]Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998, 339(8):520-32.
• [4]Moxnes JF, de Blasio BF, Leegaard TM, Moen AE: Methicillin-resistant Staphylococcus aureus (MRSA) is increasing in Norway: a time series analysis of reported MRSA and methicillin-sensitive S. aureus cases, 1997–2010. PLoS One 2013, 8(8):e70499.
• [5]Benfield T, Espersen F, Frimodt-Moller N, Jensen AG, Larsen AR, Pallesen LV, et al.: Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007, 13(3):257-63.
• [6]Huggan PJ, Murdoch DR, Gallagher K, Chambers ST: Concomitant Staphylococcus aureus bacteriuria is associated with poor clinical outcome in adults with S. aureus bacteraemia. J Hosp Infect 2008, 69(4):345-9.
• [7]Mejer N, Westh H, Schonheyder HC, Jensen AG, Larsen AR, Skov R, et al.: Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC Infect Dis 2012, 12:260. BioMed Central Full Text
• [8]Kaasch AJ, Barlow G, Edgeworth JD, Fowler VG Jr, Hellmich M, Hopkins S, et al.: Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 2014, 68(3):242-51.
• [9]Asgeirsson H, Gudlaugsson O, Kristinsson KG, Heiddal S, Kristjansson M: Staphylococcus aureus bacteraemia in Iceland, 1995–2008: changing incidence and mortality. Clin Microbiol Infect 2011, 17(4):513-8.
• [10]Mansur N, Hazzan R, Paul M, Bishara J, Leibovici L: Does sex affect 30-day mortality in Staphylococcus aureus bacteremia? Gend Med 2012, 9(6):463-70.
• [11]Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N: Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002, 162(1):25-32.
• [12]Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, et al.: Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis 2003, 37(6):794-9.
• [13]van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB: Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev 2012, 25(2):362-86.
• [14]Laupland KB, Lyytikainen O, Sogaard M, Kennedy KJ, Knudsen JD, Ostergaard C, et al.: The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 2013, 19(5):465-71.
• [15]Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al.: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29(4):530-8.
• [16]Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39(2):165-228.
• [17]Krokstad S, Langhammer A, Hveem K, Holmen TL, Midthjell K, Stene TR, et al.: Cohort profile: the HUNT study, Norway. Int J Epidemiol 2013, 42(4):968-77.
• [18]Nolte FS, Williams JM, Jerris RC, Morello JA, Leitch CD, Matushek S, et al.: Multicenter clinical evaluation of a continuous monitoring blood culture system using fluorescent-sensor technology (BACTEC 9240). J Clin Microbiol 1993, 31(3):552-7.
• [19]Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, Kirby A, Tilley R, Torok ME, et al.: Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis 2011, 11(3):208-22.
• [20]Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al.: Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137(10):791-7.
• [21]Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH: Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 2006, 34(10):2588-95.
• [22]Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-83.
• [23]Chow JW, Yu VL: Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999, 11(1):7-12.
• [24]Muder RR, Brennen C, Rihs JD, Wagener MM, Obman A, Stout JE, et al.: Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia. Clin Infect Dis 2006, 42(1):46-50.
• [25]Fortin E, Rocher I, Frenette C, Tremblay C, Quach C: Healthcare-associated bloodstream infections secondary to a urinary focus: the Quebec provincial surveillance results. Infect Control Hosp Epidemiol 2012, 33(5):456-62.
• [26]Jacobsson G, Nasic S: Long-term outcome of invasive Staphylococcus aureus infections. Scand J Infect Dis 2012, 44(5):350-4.
• [27]Wyllie DH, Crook DW, Peto TE: Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ (Clin Res Ed) 2006, 333(7562):281.
• [28]Hanses F, Spaeth C, Ehrenstein BP, Linde HJ, Scholmerich J, Salzberger B: Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection 2010, 38(6):465-70.
• [29]Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C, et al.: Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003, 24(12):890-6.
• [30]Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R, et al.: Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001, 31(2):97-103.
• [31]Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, et al.: Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock (Augusta, Ga) 2009, 31(2):146-50.
• [32]Mylotte JM, Tayara A: Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000, 31(5):1170-4.
• [33]Chihara S, Popovich KJ, Weinstein RA, Hota B: Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case–control study. BMC Infect Dis 2010, 10:225. BioMed Central Full Text
• [34]Asgeirsson H, Kristjansson M, Kristinsson KG, Gudlaugsson O: Clinical significance of Staphylococcus aureus bacteriuria in a nationwide study of adults with S. aureus bacteraemia. J Infect 2012, 64(1):41-6.
• [35]Rasmussen RV, Host U, Arpi M, Hassager C, Johansen HK, Korup E, et al.: Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr 2011, 12(6):414-20.
• [36]Lodise TP, McKinnon PS, Swiderski L, Rybak MJ: Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36(11):1418-23.
• [37]Antibiotika i sykehus. IK-2737. In: Statens Helsetilsyn; 2001.
• [38]Rieg S, Peyerl-Hoffmann G, de With K, Theilacker C, Wagner D, Hubner J, et al.: Mortality of S. aureus bacteremia and infectious diseases specialist consultation–a study of 521 patients in Germany. J Infect 2009, 59(4):232-9.
• [39]Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, et al.: Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998, 27(3):478-86.
• [40]Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK: The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 2010, 123(7):631-7.
• [41]Lopez-Cortes LE, Del Toro MD, Galvez-Acebal J, Bereciartua-Bastarrica E, Farinas MC, Sanz-Franco M, et al.: Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 2013, 57(9):1225-33.
• [42]Borde JP, Batin N, Rieg S, Feik R, Reimling C, Kern WV, et al.: Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital. Infection 2014, 42(4):713-9.